Company / Assets per Share
REGENXBIO Inc. Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$9.14
FY2025
5-year range
$9.14 / $29.72
FY2021-FY2025
Trend
-13.6%
vs FY2024
Sector context
#105 of 210
Health Care
What the data says
At $9.14, REGENXBIO Inc.'s assets per share ranks #105 of 210 in the Health Care sector. Assets per Share has declined for 4 consecutive years, from $29.72 in FY2021 to $9.14 in FY2025.
Based on SEC 10-K filings.
9.14 in FY2025 with a 5-year CAGR of -13.7%.
Declined from $13.26 to $9.14 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -22.3%
- 5-Year CAGR
- -13.7%
- 10-Year CAGR
- -
Sector benchmark
#105 of 210 in Health CareTop 50% of 210This company $9.14 Sector average $296.79
▼
-96.9% below sector average
Key checks
Key Insights
- REGENXBIO Inc.'s assets per share has declined for 4 consecutive years.
- In FY2025, assets per share decreased 13.6% year-over-year.
- Ranks #105 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -2.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.14 | -13.6% |
| FY2024 | $10.58 | -20.2% |
| FY2023 | $13.26 | -31.9% |
| FY2022 | $19.45 | -34.5% |
| FY2021 | $29.72 | +55.3% |
| FY2020 | $19.14 | +38.9% |
| FY2019 | $13.78 | -20.7% |
| FY2018 | $17.38 | +131.6% |
| FY2017 | $7.50 | +14.3% |
| FY2016 | $6.56 | -92.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026